Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

SIDAPVIA is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and sitagliptin is appropriate.
Limitations of use: SIDAPVIA is not indicated for use in patients with type 1 diabetes mellitus.
SIDAPVIA should not be used for the treatment of diabetic ketoacidosis.
SIDAPVIA has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using SIDAPVIA (see Precautions).

Sidapvia Indications/Uses

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma